| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |